Article

Ischaemic jejunal vasculitis during treatment with pegylated interferon-alpha 2b and ribavirin for hepatitis C virus related cirrhosis.

Department of Internal Medicine and Dermatology, Catholic University of the Sacred Heart, Rome, Italy.
Digestive and Liver Disease (impact factor: 3.05). 06/2006; 38(5):352-4. DOI:10.1016/j.dld.2005.07.008 pp.352-4
Source: PubMed

ABSTRACT A 53-year-old male with compensated cirrhosis (Child-Pugh class A5) and mixed cryoglobulinaemia (cryocrit: 2.0%), both hepatitis C virus-related, was treated with pegylated interferon-alpha 2b and ribavirin. After three months of therapy, he developed segmental jejunal vasculitis requiring emergency resection of an ischaemic intestinal loop 60cm long. Pathological examination of the surgical specimen revealed signs of ischaemic injury with haemorrhagic infarction due to arteritis and arterial occlusion. The postoperative course was complicated by progressive liver and renal failure that led to the patient's death six months after surgery. To our knowledge, ischaemic jejunal vasculitis has never been reported during interferon therapy, but the latter treatment may have played causative roles.

0 0
 · 
0 Bookmarks
 · 
29 Views
Data provided are for informational purposes only. Although carefully collected, accuracy cannot be guaranteed. The impact factor represents a rough estimation of the journal's impact factor and does not reflect the actual current impact factor. Publisher conditions are provided by RoMEO. Differing provisions from the publisher's actual policy or licence agreement may be applicable.

Keywords

arterial occlusion
 
compensated cirrhosis
 
cryocrit
 
ischaemic injury
 
ischaemic intestinal loop 60cm
 
ischaemic jejunal vasculitis
 
Pathological examination
 
patient's death
 
pegylated interferon-alpha 2b
 
progressive liver
 
renal failure
 
ribavirin
 
segmental jejunal vasculitis